The IPO of Jay Ambe Supermarkets in India has been oversubscribed by 60 times while the demand for the IPO of Galaxy Medicare was only 1.8 times indicating diverging investor sentiments in the SME sector.
Jay Ambe IPO Surges 60x
On September 12, 2025, the SME IPO scene in India presented a tale of extremely different outcomes. Corporate details of the Gujarati retail chain of City Square Mart brand revealed that its IPO was 59.87 times oversubscribed, but a healthcare device company from Odisha got a subscription of 1.8 only.
The standoff clearly indicates that Indian investor sentiment is heavily tilted towards real objects, especially consumer-centric businesses, and away from the likes of healthcare manufacturing sectors.
Retail Fever Drives Massive Oversubscription
Jay Ambe Supermarkets was planning to collect Rs 18.45 crore through its public offer that was priced at Rs 74–78 per share, the upper end. The IPO went for subscriptions to the extent of 59.87 times, and there were offers for 10.12 crore shares against the issue of 16.92 lakh shares, which may be termed as a day of historic exuberance.
Subscription numbers broken down:
- Non-institutional investors: 81.88x
- Retail investors: 71.65x
- Qualified institutional buyers: 16.79x
Rising disposable incomes and the retail boom in Gujarat are the two reasons identified by experts for such enviable demand chiefly. The investors saw the City Square Mart model as a future proof business backed by the plans for immediate geographical expansion.
Investor Psychology: Why Galaxy Medicare Lagged
The public issue of Galaxy Medicare planned to raise Rs 22.31 crore by floating 41.32 lakh shares and got offers for 73.98 lakh shares. However, the attraction was very low when compared to the Jay Ambe IPO.
There were several reasons for this:
- Sector familiarity: It is much easier for investors to understand and relate to a retail business than a medical device one.
- Growth potential perception: With retail, growth is always by increasing sales and expanding the business; with the medtech field, it is the tight regulations and a relatively small market.
- Visibility: Jay Ambe has 17 stores spread across Gujarat, on the other side, Galaxy Medicare is an B2B company.
One major factor, according to investors in the SME market, that decides whether the subscription is made or not is the clarity of the growth story and visibility in the market.
Allocation Challenges and Market Dynamics
Due to the huge demand for Jay Ambe, there was a problem with how shares were distributed. There were a total of 21,236 applications which meant that many retail investors only got a part of what they had applied for. On the other hand, due to lower demand, most investors probably got full allocation in Galaxy Medicare.
QIBs did not hesitate in letting their money go into the Jay Ambes project to manifest their confidence in retail to scale up and provide stable returns. Platforms such as BSE SME and NSE Emerge are becoming more and more the places where small businesses can attract a wide range of investors efficiently.
Strategic Use of IPO Proceeds
Jay Ambe is planning to spend the IPO money on:
- The purchase of an already operating store in Ahmedabad
- The fit-out of three new stores
- Working capital and general corporate purposes
Galaxy Medicare will use the money they raise to:
- Invest in equipment for their Bhubaneswar facility
- Meet their working capital needs
- Help with the general corporate objectives
Clearly, while both companies have viable expansion plans, investors were more inclined towards the solid growth of the retail chain.
Broader Implications for India’s SME IPO Market
The differences in subscription patterns show a broader trend: companies that have a customer base and are visibly gaining market share are more likely to attract investors’ interest than those from niches that are little known.
Oversubscription represents high market confidence; however, it also causes allocation issues, mainly for retail investors. The experts say that although oversubscription does not guarantee a rise in price after listing, it is an indication of strong investor sentiment and sectoral attractiveness.
“These IPOs unveil that the business story can be a factor in the investors behavior as much as the financials,” an NSE market analyst said.
Looking Ahead: Trading and Market Expectations
Trading of both IPOs will start on September 17, 2025, but on different exchanges: Jay Ambe will be at BSE SME and Galaxy Medicare at NSE Emerge. According to market watchers, the scenario will be vibrant for Jay Ambe with possible listing gains, while Galaxy Medicare will most likely see a slow pace.
Analysts and investors will watch the run very closely to decide whether the market mood observed in the primary market is reflected in the secondary market.
In the end, the public issue of Jay Ambe Supermarkets is an example of how India's retail industry continues to lure investors and the niche healthcare manufacturing sector is still struggling with attracting a patient and selective audience.
FAQ’s
City Square Mart is what?
City Square Mart is a grocery and daily needs retail chain operating in Gujarat, India. It is a part of Jay Ambe Supermarkets.
How many City Square Mart stores are there in Gujarat?
Until 2025, City Square Mart has opened 17 stores spread across Gujarat.
Who is City Square Mart?
The company behind City Square Mart is Jay Ambe Supermarkets Ltd., a leader in the Indian retail sector.
What is an SME IPO?
An SME IPO is the process when a Small and Medium Enterprise publicly offers its shares to raise funds on the BSE SME or NSE Emerge platform.
How can investors participate in an SME IPO?
Investors are allowed to submit their applications through their brokerage accounts or online trading accounts on the SME platform where the IPO is listed.
READ MORE ON